These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23568565)

  • 1. GH/IGF1 axis disturbances in the fibromyalgia syndrome: is there a rationale for GH treatment?
    Cuatrecasas G; Alegre C; Casanueva FF
    Pituitary; 2014 Jun; 17(3):277-83. PubMed ID: 23568565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibromyalgic syndromes: could growth hormone therapy be beneficial?
    Cuatrecasas G
    Pediatr Endocrinol Rev; 2009 Jun; 6 Suppl 4():529-33. PubMed ID: 19550388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone as concomitant treatment in severe fibromyalgia associated with low IGF-1 serum levels. A pilot study.
    Cuatrecasas G; Riudavets C; Güell MA; Nadal A
    BMC Musculoskelet Disord; 2007 Nov; 8():119. PubMed ID: 18053120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-1 axis in patients with fibromyalgia syndrome.
    Leal-Cerro A; Povedano J; Astorga R; Gonzalez M; Silva H; Garcia-Pesquera F; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3378-81. PubMed ID: 10487713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum ghrelin levels but not GH, IGF-1 and IGFBP-3 levels are altered in patients with fibromyalgia syndrome.
    Tander B; Atmaca A; Aliyazicioglu Y; Canturk F
    Joint Bone Spine; 2007 Oct; 74(5):477-81. PubMed ID: 17689128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment options.
    Kemp SF
    BioDrugs; 2009; 23(3):155-63. PubMed ID: 19627167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of leptin, growth hormone, and insulin-like growth factor levels with body mass index and disease severity in patients with fibromyalgia syndrome.
    Koca TT; Berk E; Seyithanoğlu M; Koçyiğit BF; Demirel A
    Acta Neurol Belg; 2020 Jun; 120(3):595-599. PubMed ID: 30547374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The GH-IGF1 axis and longevity. The paradigm of IGF1 deficiency.
    Laron Z
    Hormones (Athens); 2008; 7(1):24-7. PubMed ID: 18359741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis.
    Häuser W; Wolfe F; Tölle T; Uçeyler N; Sommer C
    CNS Drugs; 2012 Apr; 26(4):297-307. PubMed ID: 22452526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone deficiency and human immunodeficiency virus.
    Rochira V; Guaraldi G
    Best Pract Res Clin Endocrinol Metab; 2017 Feb; 31(1):91-111. PubMed ID: 28477736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of growth hormone deficiency in severe fibromyalgia syndromes.
    Cuatrecasas G; Gonzalez MJ; Alegre C; Sesmilo G; Fernandez-Solà J; Casanueva FF; Garcia-Fructuoso F; Poca-Dias V; Izquierdo JP; Puig-Domingo M
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4331-7. PubMed ID: 20631018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of IGF1 estimation in adults with GH deficiency.
    Mukherjee A; Shalet SM
    Eur J Endocrinol; 2009 Nov; 161 Suppl 1():S33-9. PubMed ID: 19684059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiency.
    Giavoli C; Profka E; Verrua E; Ronchi CL; Ferrante E; Bergamaschi S; Sala E; Malchiodi E; Lania AG; Arosio M; Ambrosi B; Spada A; Beck-Peccoz P
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3983-8. PubMed ID: 22904173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatopause: dismetabolic and bone effects.
    Lombardi G; Tauchmanova L; Di Somma C; Musella T; Rota F; Savanelli MC; Colao A
    J Endocrinol Invest; 2005; 28(10 Suppl):36-42. PubMed ID: 16550721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the GH-IGF1 system in progression of cancer.
    Werner H; Laron Z
    Mol Cell Endocrinol; 2020 Dec; 518():111003. PubMed ID: 32919021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults.
    Woodhouse LJ; Mukherjee A; Shalet SM; Ezzat S
    Endocr Rev; 2006 May; 27(3):287-317. PubMed ID: 16543384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GH therapy and cancer risk in hypopituitarism: what we know from human studies.
    Pekic S; Popovic V
    Eur J Endocrinol; 2013 Nov; 169(5):R89-97. PubMed ID: 23935131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can an Aerobic Exercise Programme Improve the Response of the Growth Hormone in Fibromyalgia Patients? A Randomised Controlled Trial.
    Estrada-Marcén NC; Casterad-Seral J; Montero-Marin J; Serrano-Ostáriz E
    Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocentric study of 112 consecutive patients with childhood onset GH deficiency around and after transition.
    Courtillot C; Baudoin R; Du Souich T; Saatdjian L; Tejedor I; Pinto G; Léger J; Polak M; Golmard JL; Touraine P;
    Eur J Endocrinol; 2013 Nov; 169(5):587-96. PubMed ID: 23939920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GH and the cardiovascular system: an update on a topic at heart.
    Isgaard J; Arcopinto M; Karason K; Cittadini A
    Endocrine; 2015 Feb; 48(1):25-35. PubMed ID: 24972804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.